Blog

Focused Ultrasound Combination Therapy for DIPG Earns FDA’s Fast Track Designation

Published: 6 December 2023

The US Food and Drug Administration (FDA) has granted Fast Track designation to the combination of SonALAsense’s proprietary drug and Insightec’s focused ultrasound device for the treatment of pediatric brain tumors.

Insightec Granted Permanent Reimbursement Code for Brain Treatments

Published: 6 December 2023

The American Medical Association has issued a category I CPT® code for treating essential tremor (ET) and Parkinson’s disease with Insightec’s Exablate Neuro focused ultrasound device.

Company Profile: EXACT Therapeutics AS

Published: 14 November 2023

EXACT Therapeutics AS is a clinical-stage biopharmaceutical company headquartered in Oslo, Norway. The company is developing Acoustic Cluster Therapy (ACT®), a novel ultrasound-mediated technology platform for delivering targeted therapeutics.

FDA Grants Breakthrough Device Designation for Cordance Medical’s Brain Tumor Liquid Biopsy Platform

Published: 25 October 2023

The company’s NeuroAccess™ platform is designed to noninvasively open the blood-brain barrier for liquid biopsy and drug delivery applications.

Company Profile: Brainlab

Published: 28 September 2023

Brainlab is a global medical software and hardware company dedicated to improving patient outcomes by catalyzing access to and the consistency of medical treatments.

New ARPA-H Program Could Enable Innovative and Accessible Focused Ultrasound Systems Meeting Report: American Urological Association (AUA) 2023 Annual Meeting Why It Takes So Long to Develop a Medical Technology (Part 13) Why It Takes So Long to Develop a Medical Technology (Part 12) Ultrasound Cavitation Improves Delivery of Pancreatic Cancer Therapies